Deferred Tax Assets, Valuation Allowance of Pulmonx Corp from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Pulmonx Corp quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Pulmonx Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $100,491,000, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Pulmonx Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $100,491,000 +$9,893,000 +11% 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q4 2024 $90,598,000 +$11,236,000 +14% 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q4 2023 $79,362,000 +$10,935,000 +16% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q4 2022 $68,427,000 +$11,876,000 +21% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q4 2021 $56,551,000 +$14,629,000 +35% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q4 2020 $41,922,000 +$12,969,000 +45% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $28,953,000 +$4,217,000 +17% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q4 2018 $24,736,000 31 Dec 2018 10-K 15 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.